New inhaler begins human testing for chronic lung disease
NCT ID NCT07116915
Summary
This early-stage study is checking the safety and how the body processes a new inhaler medication called HRS-9821. It will test a single dose in 160 healthy volunteers and multiple doses in people with COPD. The main goal is to see what side effects occur and how the drug moves through the body, which is the first step in developing a potential new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
West China Hospital, Sichuan University
RECRUITINGChengdu, Sichuan, 610044, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.